Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
ENTX
$2.58
-1.72%
ENTX
· Entera Bio Ltd.
$2.58
-0.05 (-1.72%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 7, 2026
The latest filing states the doubt was alleviated.
“Following the closing of the private placement and receipt of the related net proceeds, management concluded that substantial doubt about the Company’s ability to continue as a going concern no longer exists.”View the 10-Q filed Aug 7, 2026
Market Cap
$453.63M
Shares
173.14M
Volume · Oct 6
460.31K
Avg daily vol (3M)
1.79M
All webcasts
Earnings call · FY2021 Q4
Entera Bio Ltd. (ENTX) Q4 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$165,000
Gross margin · derived Q4
17.6%
Net income · derived Q4
-$4.10M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 8, 2022 · complete as-filed document
SEC periodic report
10-K report
Filed Apr 29, 2022 · complete as-filed document